![Debbie Carter](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Debbie Carter
Chief Investment Officer at Hoverink Capital Management LLC
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Cyrus Sajna | M | 42 |
Hoverink Capital Management LLC
![]() Hoverink Capital Management LLC Investment ManagersFinance Hoverink Capital Management LLC (Hoverink Capital Management) is a private equity firm founded in Founded in 2015. The firm is headquartered in Grapevine,Texas. | 9 years |
Davidra Nicole Sajna | F | - |
Hoverink Biotechnologies, Inc.
![]() Hoverink Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Hoverink Biotechnologies, Inc. operates as a biopharmaceutical company, which discovers, develops, manufactures, and commercializes pharmaceutical preparations and drug treatment for age-related diseases, cancer, gastrointestinal and oncological diseases and disorders. Its product candidate includes Ladavru, which is developed for treating cirrhosis ascites, cirrhosis, AIDS, and chronic pain, nausea and discomfort associated with chemotherapy. The company was founded by Cyrus Sajna on July 2, 2013 and is headquartered in Los Angeles, CA. | 9 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
James Cassidy | M | 88 |
Hoverink Biotechnologies, Inc.
![]() Hoverink Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Hoverink Biotechnologies, Inc. operates as a biopharmaceutical company, which discovers, develops, manufactures, and commercializes pharmaceutical preparations and drug treatment for age-related diseases, cancer, gastrointestinal and oncological diseases and disorders. Its product candidate includes Ladavru, which is developed for treating cirrhosis ascites, cirrhosis, AIDS, and chronic pain, nausea and discomfort associated with chemotherapy. The company was founded by Cyrus Sajna on July 2, 2013 and is headquartered in Los Angeles, CA. | - |
James McKillop | M | 64 |
Hoverink Biotechnologies, Inc.
![]() Hoverink Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Hoverink Biotechnologies, Inc. operates as a biopharmaceutical company, which discovers, develops, manufactures, and commercializes pharmaceutical preparations and drug treatment for age-related diseases, cancer, gastrointestinal and oncological diseases and disorders. Its product candidate includes Ladavru, which is developed for treating cirrhosis ascites, cirrhosis, AIDS, and chronic pain, nausea and discomfort associated with chemotherapy. The company was founded by Cyrus Sajna on July 2, 2013 and is headquartered in Los Angeles, CA. | - |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 4 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Debbie Carter
- Personal Network